As part of the France 2030 Investment Plan launched by the French government, PEPR PROPSY, with the support of Fondation FondaMental, was selected to strengthen clinical and pre-clinical research in precision psychiatry.
A central component of PROPSY is the development of French Minds, a large-scale longitudinal and deeply phenotyped cohort supported by a multimodal database.
Le PEPR PROPSY, représenté par l’INSERM, ainsi que la Fondation FondaMental et le NIHR MH-TRC, ont conclu un protocole d’accord (Memorandum of Understanding) afin de formaliser un consortium ayant pour objectif commun de faire progresser la psychiatrie de précision.
PEPR PROPSY, represented by INSERM, along with Fondation FondaMental and the NIHR MH-TRC, entered into a Memorandum of Understanding to formalises a consortium, with the shared intent to advance precision psychiatry, through :
- reciprocal access to datasets and biosample cohorts,
- the harmonisation of blood-sampling criteria and multi-omics workflows,
- joint projects on genomic and immuno-metabolic biomarkers,
- exchanges of researchers and students,
- coordinated efforts to secure external funding with public- and private-sector partners.
This Consortium will take place in London, on April 13-14, 2026.
A call for applications has been opened for doctoral and postdoctoral students to encourage their participation in the Consortium. They will :
- Showcase their research to international experts
- Engage in discussions on mental health biomarkers
- Network with leading UK and French scientists
The Consortium program is here.